Irland - Englisch - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril tert-butylamine, indapamide - tablets - 8/2.5 mg/mg - ace inhibitors and diuretics

Irland - Englisch - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril tert-butylamine salt - tablets - 8 milligram

Irland - Englisch - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril tert-butylamine salt - tablets - 2 milligram

Irland - Englisch - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril tert-butylamine salt - tablets - 4 milligram

Irland - Englisch - HPRA (Health Products Regulatory Authority)

les laboratoires servier - atorvastatin; perindopril arginine; amlodipine - film-coated tablet - 10 mg/5 mg/5 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz atorvastatin, amlodipine and perindopril - : lipid modifying agents, hmg coa reductase inhibitors, other combinations - triveram is indicated for the treatment of essential hypertension and/or stable coronary artery disease, in association with primary hypercholesterolaemia or mixed hyperlipidaemia, as substitution therapy in adult patients adequately controlled with atorvastatin, perindopril and amlodipine given concurrently at the same dose level as in the combination.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

les laboratoires servier - atorvastatin; perindopril arginine; amlodipine - film-coated tablet - 20 mg/5 mg/5 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz atorvastatin, amlodipine and perindopril - : lipid modifying agents, hmg coa reductase inhibitors, other combinations - triveram is indicated for the treatment of essential hypertension and/or stable coronary artery disease, in association with primary hypercholesterolaemia or mixed hyperlipidaemia, as substitution therapy in adult patients adequately controlled with atorvastatin, perindopril and amlodipine given concurrently at the same dose level as in the combination.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

les laboratoires servier - atorvastatin; perindopril arginine; amlodipine - film-coated tablet - 20 mg/10 mg/5 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz atorvastatin, amlodipine and perindopril - : lipid modifying agents, hmg coa reductase inhibitors, other combinations - triveram is indicated for the treatment of essential hypertension and/or stable coronary artery disease, in association with primary hypercholesterolaemia or mixed hyperlipidaemia, as substitution therapy in adult patients adequately controlled with atorvastatin, perindopril and amlodipine given concurrently at the same dose level as in the combination.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

les laboratoires servier - atorvastatin; perindopril arginine; amlodipine - film-coated tablet - 20 mg/10 mg/10 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz atorvastatin, amlodipine and perindopril - lipid modifying agents, hmg coa reductase inhibitors, other combinations - triveram is indicated for the treatment of essential hypertension and/or stable coronary artery disease, in association with primary hypercholesterolaemia or mixed hyperlipidaemia, as substitution therapy in adult patients adequately controlled with atorvastatin, perindopril and amlodipine given concurrently at the same dose level as in the combination

Irland - Englisch - HPRA (Health Products Regulatory Authority)

les laboratoires servier - atorvastatin; perindopril arginine; amlodipine - film-coated tablet - 40 mg/10 mg/10 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz atorvastatin, amlodipine and perindopril - lipid modifying agents, hmg coa reductase inhibitors, other combinations - triveram is indicated for the treatment of essential hypertension and/or stable coronary artery disease, in association with primary hypercholesterolaemia or mixed hyperlipidaemia, as substitution therapy in adult patients adequately controlled with atorvastatin, perindopril and amlodipine given concurrently at the same dose level as in the combination.

Europäische Union - Englisch - EMA (European Medicines Agency)

les laboratoires servier - strontium ranelate - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of severe osteoporosis in postmenopausal women at high risk for fracture to reduce the risk of vertebral and hip fractures.treatment of severe osteoporosis in adult men at increased risk of fracture.the decision to prescribe strontium ranelate should be based on an assessment of the individual patient's overall risks.